Research Study Summary
CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia
Objective: To determine the safe and tolerable dose of midostaurin in combination with azacitidine in patients with acute myelogenous leukemia.
To Learn more
Date Last Changed:
July 19, 2013
Clinical Trial Snapshot
- Both Male and Female
- Overall Status
- Facility Type
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.